Problem statement: Answer the multiple-choice question.
Query: Which drug has a 2.856% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CCC(C(=O)O)N1C(=O)C2CCCCC2C1=O
b. O=C(CCCc1nc(-c2ccccc2)no1)Nc1cccnc1
c. N#Cc1ccc(C(=O)Nc2nnc(-c3ccccn3)o2)cc1
d. Cc1sc2ncn(CC(=O)NCCN3CCOCC3)c(=O)c2c1S(=O)(=O)N1CCC(C)CC1
Answer: a. CCC(C(=O)O)N1C(=O)C2CCCCC2C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)O)N1C(=O)C2CCCCC2C1=O
CCC(C(=O)O)N1C(=O)C2CCCCC2C1=O
2-(1-hydroxy-1-oxobutan-2-yl)-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione